• Generic selectors
    Exact matches only
    Search in title
    Search in content
    Post Type Selectors
    Filter by Categories
  • URX@UniversalRx.com

News Archives - Universal Rx

Zantac Is Voluntarily Recalled After Cancer-Causing Chemical Detected

Oct 22, 2019

The pharmaceutical company Sanofi announced today that it’s undertaking a voluntary recall of Zantac due to concerns about a potential cancer-causing chemical.     Read the full article at HealthLine.com: HEALTHLINE.COM/HEALTH-NEWS/FDA-WARNS-ZANTAC-MAY-HAVE-CARCINOGEN

Continue Reading
Photo by Louis Reed

The Changing Landscape of Multiple Sclerosis Treatment

Oct 16, 2019

In the first quarter of 2019, two new Multiple Sclerosis (MS) medications were approved by the Food and Drug Administration (FDA) and there are many more on the horizon for approval. MS is a complicated disease that impacts approximately 1 million people in the U.S. and affects every patient differently. It attacks the central nervous

Continue Reading

Ten Fitness Tips to Take You from Good to Great

Jul 23, 2019

There are hundreds – if not thousands – of different exercise programs and regimes out there that all claim to be the best. There are even more “miracle diets” advertised. It can be confusing trying to decide which are fads and which actually work. However, one thing is crystal clear: if you’ve been following a

Continue Reading

Treatment Developments Could Reduce Severity of Reactions for Peanut Allergy Sufferers.

Jul 16, 2019

In the United States, approximately 32 million people have food allergies, defined as an adverse health effect resulting from a specific immune response that occurs on exposure to a given food. The allergic reaction occurs because the immune system attacks the food proteins that are normally harmless. Reactions can vary from mild, such as rash

Continue Reading

When Hives Don’t Go Away

Jul 02, 2019

For many, allergic reactions cause symptoms like a runny nose or watery eyes. Others experience hives, a common skin reaction involving red, itchy, rash-like marks. Hives usually go away on their own within a few days to a week. But for some, hives become a chronic, or long-term, issue. If you develop hives and they

Continue Reading

Finding a Link Between Antihypertensive Drug Use and Dementia

Jun 17, 2019

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence. Little is known about the way in which such programs can be implemented in actual care practice. However, it may be possible to use data from clinical practice to estimate the potential of drug prescriptions to

Continue Reading

Treatment for Rare Autoimmune Disorder Receives FDA Approval

Dec 04, 2018

“This FDA approval marks the arrival of a first-in-class therapy for a rare and devastating condition with limited treatment options,” Gary Ingenito, MD, PhD, chief medical officer and head of regulatory affairs at Catalyst, said in a statement.2 “We extend our deepest gratitude to the patients who participated in the Firdapse clinical trials and their families

Continue Reading

FDA Gives OK to First New Flu Drug in 20 Years

Dec 04, 2018

For the first time in two decades, the U.S. Food and Drug Administration has approved a new type of antiviral flu drug. The single oral dose of Xofluza (baloxavir marboxil) is for the treatment of uncomplicated flu in patients aged 12 and older who have had symptoms for no more than 48 hours. Read More

Continue Reading

Can EpiPens Still Work After Freezing?

Dec 04, 2018

The epinephrine auto-injector can be lifesaving in cases of severe allergic reaction, and millions of Americans carry the devices. But what happens if your auto-injector freezes, will it still work? Is the medication still the same? Read More

Continue Reading

FDA Approves First Generic Version of EpiPen

Mar 31, 2018

THE FOOD AND DRUG Administration has approved the first generic version of the EpiPen to treat emergent and potentially life-threatening allergic reactions. The generic version of EpiPen and EpiPen Jr., manufactured by Teva Pharmaceuticals, received the FDA’s stamp of approval this week to market its generic epinephrine auto-injector in two different strengths, according to a

Continue Reading